These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36461391)

  • 1. Differential responses on gut microbiota and microbial metabolome of 2'-fucosyllactose and galactooligosaccharide against DSS-induced colitis.
    Liu X; Zhang Y; Li W; Yin J; Zhang B; Wang J; Wang S
    Food Res Int; 2022 Dec; 162(Pt B):112072. PubMed ID: 36461391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactooligosaccharide or 2'-Fucosyllactose Modulates Gut Microbiota and Inhibits LPS/TLR4/NF-κB Signaling Pathway to Prevent DSS-Induced Colitis Aggravated by a High-Fructose Diet in Mice.
    Chen T; Wang C; Nie C; Yuan X; Tu A; Li J
    J Agric Food Chem; 2023 Jun; 71(24):9349-9360. PubMed ID: 37290013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Fucosyllactose Promotes Colonization of
    Liu X; Zhang B; Zhang Y; Li W; Yin J; Shi A; Wang J; Wang S
    J Agric Food Chem; 2024 Mar; 72(9):4765-4776. PubMed ID: 38393978
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of
    Mao B; He Z; Chen Y; Stanton C; Ross RP; Zhao J; Chen W; Yang B
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
    Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation.
    Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S
    PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL).
    Coulet M; Phothirath P; Allais L; Schilter B
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):59-69. PubMed ID: 24262411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
    Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
    Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
    Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
    Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades.
    Wang K; Guo J; Chang X; Gui S
    J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive and Prebiotic Effect of α-Galacto-Oligosaccharide against Dextran Sodium Sulfate-Induced Colitis and Gut Microbiota Dysbiosis in Mice.
    He N; Wang Y; Zhou Z; Liu N; Jung S; Lee MS; Li S
    J Agric Food Chem; 2021 Aug; 69(33):9597-9607. PubMed ID: 34378931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: Genotype-phenotype association analysis revealed different utilization ability of 2'-fucosyllactose in Bifidobacterium genus.
    He Z; Yang B; Liu X; Ross RP; Stanton C; Zhao J; Zhang H; Chen W
    J Dairy Sci; 2021 Feb; 104(2):1518-1523. PubMed ID: 33358168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of a novel α-L-fucosidase from Pedobacter sp. and its application in synthesis of 3'-fucosyllactose and 2'-fucosyllactose.
    Shi R; Ma J; Yan Q; Yang S; Fan Z; Jiang Z
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5813-5826. PubMed ID: 32388762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2'FL and LNnT Exert Antipathogenic Effects against
    Vigsnaes LK; Ghyselinck J; Van den Abbeele P; McConnell B; Moens F; Marzorati M; Bajic D
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451391
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture.
    Nogacka AM; Cuesta I; Gueimonde M; de Los Reyes-Gavilán CG
    Microorganisms; 2023 Oct; 11(11):. PubMed ID: 38004671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human milk oligosaccharide 2'-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice.
    Paone P; Latousakis D; Terrasi R; Vertommen D; Jian C; Borlandelli V; Suriano F; Johansson MEV; Puel A; Bouzin C; Delzenne NM; Salonen A; Juge N; Florea BI; Muccioli GG; Overkleeft H; Van Hul M; Cani PD
    Gut; 2024 Sep; 73(10):1632-1649. PubMed ID: 38740509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fermentation characteristics of select nondigestible oligosaccharides by infant fecal inocula.
    Vester Boler BM; Rossoni Serao MC; Faber TA; Bauer LL; Chow J; Murphy MR; Fahey GC
    J Agric Food Chem; 2013 Mar; 61(9):2109-19. PubMed ID: 23379900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
    Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
    Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
    Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Probiotic Modulation of the Intestinal Microbiota and 2'Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age.
    Nogacka AM; Arboleya S; Nikpoor N; Auger J; Salazar N; Cuesta I; Alvarez-Buylla JR; Mantecón L; Solís G; Gueimonde M; Tompkins TA; de Los Reyes-Gavilán CG
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.